PINK:XSNX

Xsunx Stock Insider Trading

Healthcare > Biotechnology

Buy XSNX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Xsunx Stock Insider Power

Based on the 88 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 36.34M and sold 3.66M XSNX shares in the last 88 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 88 transactions)	0
● Buy	36.34M shares
● Sell	3.66M shares
77% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 02, 2020 Buy	Common Stock, no par value	Martin Daniel G. Chief Executive Officer	CEO / President	0 Value: $0
Jun 02, 2020 Buy	Series A Preferred Stock, $0.01 par value per share	Martin Daniel G. Chief Executive Officer	CEO / President	0 Value: $0
Nov 26, 2007 Buy	Stock Option	Russak Michael A Director	Director	500 000 Value: $180.0K
Nov 26, 2007 Buy	Stock Option	Russak Michael A Director	Director	500 000 Value: $180.0K
Nov 12, 2007 Buy	Stock Option	Fundingsland Osmund Mark Director	Director	500 000 Value: $180.0K
Nov 12, 2007 Buy	Stock Option	Fundingsland Osmund Mark Director	Director	500 000 Value: $180.0K
Oct 23, 2007 Buy	Option P-Purchase	Anderson Thomas A Director	Director	1 500 000 Value: $540.0K
Oct 23, 2007 Buy	Option P-Purchase	Anderson Thomas A Director	Director	1 500 000 Value: $540.0K
Aug 28, 2007 Buy	Common Stock	Russak Michael A Director	Director	100 000 Value: $41.0K
Aug 28, 2007 Buy	Common Stock	Russak Michael A Director	Director	100 000 Value: $41.0K
Apr 01, 2007 Buy	Options	Huitt Jeff J CFO	C-Suite Officer	500 000 Value: $230.0K
Apr 01, 2007 Buy	Options	Huitt Jeff J CFO	C-Suite Officer	500 000 Value: $230.0K
Jul 20, 2006 Buy	Warrants	Grimes Joseph COO	C-Suite Officer	112 000 Value: $189.3K
Jul 20, 2006 Buy	Warrants	Grimes Joseph COO	C-Suite Officer	112 000 Value: $189.3K
Apr 30, 2006 Sell	Common Stock G-Gift	Altounian Brian Director	Director	50 000 Value: $5K
Apr 30, 2006 Sell	Common Stock G-Gift	Altounian Brian Director	Director	350 000 Value: $35.0K
Apr 30, 2006 Sell	Common Stock G-Gift	Altounian Brian Director	Director	350 000 Value: $35.0K
Apr 30, 2006 Sell	Common Stock G-Gift	Altounian Brian Director	Director	50 000 Value: $5K
Apr 27, 2006 Sell	Common Stock S-Sale	Altounian Brian Director	Director	474 000 Value: $846.1K
Apr 27, 2006 Sell	Common Stock S-Sale	Altounian Brian Director	Director	474 000 Value: $846.1K
Apr 17, 2006 Sell	Common Stock S-Sale	Altounian Brian Director	Director	500 000 Value: $1.02M
Apr 17, 2006 Sell	Common Stock S-Sale	Altounian Brian Director	Director	500 000 Value: $1.02M
Apr 05, 2006 Buy	Options	Grimes Joseph COO	C-Suite Officer	500 000 Value: $180.0K
Apr 05, 2006 Buy	Options	Grimes Joseph COO	C-Suite Officer	500 000 Value: $230.0K
Apr 05, 2006 Buy	Warrants	Grimes Joseph COO	C-Suite Officer	500 000 Value: $255.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT XSUNX INC

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio....

Read Full Profile Here